- Home
- Publications
- Publication Search
- Publication Details
Title
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism
Authors
Keywords
-
Journal
Current Atherosclerosis Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-23
DOI
10.1007/s11883-023-01080-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lowering apolipoprotein CIII protects against high-fat diet–induced metabolic derangements
- (2021) Ismael Valladolid-Acebes et al. Science Advances
- Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia
- (2021) Yunpeng Guan et al. Frontiers in Endocrinology
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
- (2021) Henry N Ginsberg et al. EUROPEAN HEART JOURNAL
- APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups
- (2021) Shiwali Goyal et al. Lipids in Health and Disease
- Apolipoprotein CIII Reduction Protects White Adipose Tissues against Obesity-Induced Inflammation and Insulin Resistance in Mice
- (2021) Patricia Recio-López et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Apolipoprotein C‐III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria
- (2021) Fanny Jansson Sigfrids et al. JOURNAL OF INTERNAL MEDICINE
- Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects
- (2021) Marina Rodríguez et al. Journal of Proteomics
- Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study
- (2020) Julius L. Katzmann et al. Lipids in Health and Disease
- Remnant lipoproteins
- (2020) Carlos A. Aguilar Salinas et al. CURRENT OPINION IN LIPIDOLOGY
- The next generation of triglyceride-lowering drugs
- (2020) Laurens F. Reeskamp et al. CURRENT OPINION IN LIPIDOLOGY
- Network determinants of cardiovascular calcification and repositioned drug treatments
- (2020) Jun‐Seop Song et al. FASEB JOURNAL
- Human postprandial responses to food and potential for precision nutrition
- (2020) Sarah E. Berry et al. NATURE MEDICINE
- The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
- (2020) Jan Borén et al. Frontiers in Endocrinology
- Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease
- (2020) Günther Silbernagel et al. ATHEROSCLEROSIS
- ApoCIII: A multifaceted protein in cardiometabolic disease
- (2020) D’Erasmo Laura et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL)2 and the larger HDL3 from very low-density lipoprotein (VLDL)
- (2020) Azusa Yamazaki et al. BIOLOGICAL CHEMISTRY
- Identification of biomarker panels as predictors of severity in coronary artery disease
- (2020) Assia Ben Braiek et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
- (2019) Marja-Riitta Taskinen et al. Current Atherosclerosis Reports
- Targeting RNA to lower triglycerides: long strides from short molecules
- (2019) Arman Qamar et al. EUROPEAN HEART JOURNAL
- N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
- (2019) Veronica J Alexander et al. EUROPEAN HEART JOURNAL
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- (2019) Joseph L. Witztum et al. NEW ENGLAND JOURNAL OF MEDICINE
- APOC3Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular RiskHighlights
- (2018) Anders B. Wulff et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming
- (2018) Anette Christ et al. CELL
- Apolipoprotein C-III is an Amyloid-β-Binding Protein and an Early Marker for Alzheimer's Disease
- (2018) Yao-Hsiang Shih et al. JOURNAL OF ALZHEIMERS DISEASE
- Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study
- (2018) Julian C. van Capelleveen et al. Journal of Clinical Lipidology
- Increased inflammation, endoplasmic reticulum stress and oxidative stress in endothelial and macrophage cells exacerbate atherosclerosis in ApoCIII transgenic mice
- (2018) Han Yingchun et al. Lipids in Health and Disease
- Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism
- (2018) Gissette Reyes-Soffer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Remnant lipoproteins and atherosclerotic cardiovascular disease
- (2018) Hayato Tada et al. CLINICA CHIMICA ACTA
- Postprandial Hyperlipidemia and Remnant Lipoproteins
- (2017) Daisaku Masuda et al. Journal of Atherosclerosis and Thrombosis
- Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions
- (2017) Saulo Mendoza et al. Journal of Clinical Lipidology
- A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
- (2017) Sumeet A Khetarpal et al. NATURE MEDICINE
- Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death
- (2017) Adriene A. Paiva et al. Oxidative Medicine and Cellular Longevity
- High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts
- (2017) Majken K. Jensen et al. CIRCULATION
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
- (2016) Marja-Riitta Taskinen et al. Current Atherosclerosis Reports
- Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
- (2016) Andres Digenio et al. DIABETES CARE
- Effect of Leptin Administration on Circulating Apolipoprotein CIII levels in Patients With Lipodystrophy
- (2016) Andrea Kassai et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
- (2016) Philip L.S.M. Gordts et al. JOURNAL OF CLINICAL INVESTIGATION
- Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis
- (2016) Jing-Zhan Zhang et al. Aging and Disease
- Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 DiabeticsSignificance
- (2015) Arman Qamar et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII
- (2015) Haibo Li et al. CARDIOVASCULAR RESEARCH
- The pancreatic β-cell in deadly encounter with apolipoprotein CIII
- (2015) Lisa Juntti-Berggren et al. CELL CYCLE
- The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
- (2015) Frank M. Sacks CURRENT OPINION IN LIPIDOLOGY
- Association of APOC3 Loss-of-Function Mutations With Plasma Lipids and Subclinical Atherosclerosis
- (2015) Pradeep Natarajan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
- (2015) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein CIII overexpression exacerbates diet-induced obesity due to adipose tissue higher exogenous lipid uptake and retention and lower lipolysis rates
- (2015) Helena F. Raposo et al. Nutrition & Metabolism
- Apolipoprotein C-III
- (2015) Alison B. Kohan Current Opinion in Endocrinology Diabetes and Obesity
- Physiological regulation of lipoprotein lipase
- (2014) Sander Kersten BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- APOC3, Coronary Disease, and Complexities of Mendelian Randomization
- (2014) Jonathan C. Cohen et al. Cell Metabolism
- Rare Variant APOC3 R19X Is Associated With Cardio-Protective Profiles in a Diverse Population-Based Survey as Part of the Epidemiologic Architecture for Genes Linked to Environment Study
- (2014) D. C. Crawford et al. Circulation-Cardiovascular Genetics
- Postprandial lipemia as a cardiometabolic risk factor
- (2014) Angela Pirillo et al. CURRENT MEDICAL RESEARCH AND OPINION
- APOC3 mutations lower CVD risk
- (2014) Tim Geach Nature Reviews Cardiology
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion
- (2012) Chunyu Zheng et al. EUROPEAN HEART JOURNAL
- Postprandial lipoprotein metabolism: VLDL vs chylomicrons
- (2011) Katsuyuki Nakajima et al. CLINICA CHIMICA ACTA
- Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis
- (2011) Akio Kawakami et al. Journal of Atherosclerosis and Thrombosis
- Lipodystrophies: Genetic and Acquired Body Fat Disorders
- (2011) Abhimanyu Garg JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia
- (2010) Sandrine Caron et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype
- (2010) Chunyu Zheng et al. CIRCULATION
- Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins
- (2009) Carlos O. Mendivil et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Triglyceride-Rich Lipoprotein-Associated Apolipoprotein C-III Production Is Stimulated by Plasma Free Fatty Acids in Humans
- (2008) Mirjana Pavlic et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
- (2008) T. I. Pollin et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search